- Home
- JILL vs SGHT Comparison
JILL vs SGHT Comparison
Compare JILL & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JILL
- SGHT
- Stock Information
- Founded
- JILL 1959
- SGHT 2011
- Country
- JILL United States
- SGHT United States
- Employees
- JILL N/A
- SGHT N/A
- Industry
- JILL Clothing/Shoe/Accessory Stores
- SGHT Medical Specialities
- Sector
- JILL Consumer Discretionary
- SGHT Health Care
- Exchange
- JILL Nasdaq
- SGHT Nasdaq
- Market Cap
- JILL 233.1M
- SGHT 209.9M
- IPO Year
- JILL 2017
- SGHT 2021
- Fundamental
- Price
- JILL $14.19
- SGHT $4.12
- Analyst Decision
- JILL Buy
- SGHT Buy
- Analyst Count
- JILL 4
- SGHT 8
- Target Price
- JILL $29.75
- SGHT $4.01
- AVG Volume (30 Days)
- JILL 151.7K
- SGHT 157.6K
- Earning Date
- JILL 06-11-2025
- SGHT 07-31-2025
- Dividend Yield
- JILL 2.27%
- SGHT N/A
- EPS Growth
- JILL N/A
- SGHT N/A
- EPS
- JILL 2.24
- SGHT N/A
- Revenue
- JILL $602,968,000.00
- SGHT $78,109,000.00
- Revenue This Year
- JILL $1.16
- SGHT N/A
- Revenue Next Year
- JILL $2.58
- SGHT $11.60
- P/E Ratio
- JILL $6.29
- SGHT N/A
- Revenue Growth
- JILL N/A
- SGHT N/A
- 52 Week Low
- JILL $13.36
- SGHT $2.03
- 52 Week High
- JILL $40.00
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- JILL 41.77
- SGHT 64.03
- Support Level
- JILL $13.36
- SGHT $3.99
- Resistance Level
- JILL $14.64
- SGHT $4.25
- Average True Range (ATR)
- JILL 0.77
- SGHT 0.21
- MACD
- JILL -0.20
- SGHT -0.01
- Stochastic Oscillator
- JILL 27.87
- SGHT 83.54
About JILL J. Jill Inc.
J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.